Facebook
Twitter
Telegram
Report an ErrorSalarius Pharmaceuticals Financial Statements 2011-2024 | SLRX
Annual Financial Statements Salarius Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
2.02 M | 4.4 M | 821 K | 19.9 M | 8.66 M | 5.55 M | 72.3 M | 72.2 M | 117 M | - | - | - | - |
Shares |
3.26 M | 2.12 M | 1.65 M | 18 M | 3.27 M | 721 K | 690 K | 649 K | 561 K | - | - | - | - |
Historical Prices |
0.62 | 2.07 | 0.496 | 0.91 | 3.78 | 8.25 | 87.2 | 132 | 311 | - | - | - | - |
Net Income |
-12.5 M | -31.6 M | -12.8 M | -7.35 M | -6.94 M | -21.9 M | -34.4 M | -39.5 M | -29.1 M | - | - | - | - |
Revenue |
- | - | 1.84 M | 5.23 M | 3.47 M | 838 K | 1.27 M | 1.01 M | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | 431 K | 507 K | 663 K | - | - | - | - | - |
Gross Profit |
- | - | - | 5.23 M | - | 407 K | 768 K | 348 K | - | - | - | - | - |
Operating Income |
-12.9 M | -31.8 M | -12.8 M | -7.79 M | -8.27 M | -1.68 M | -34.7 M | -39.9 M | -29.2 M | -8.03 M | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-12.9 M | -31.8 M | -12.8 M | -7.33 M | -8.14 M | -21.8 M | -34.4 M | -39.6 M | -29.2 M | - | - | - | - |
Operating Expenses |
12.9 M | 31.8 M | 14.7 M | 13 M | 11.7 M | 22.5 M | 35.5 M | 40.2 M | 29.2 M | - | - | - | - |
General and Administrative Expenses |
5.72 M | 7.14 M | 6.1 M | 6.11 M | 7.71 M | 10.6 M | 18.5 M | 19.9 M | 16.5 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Salarius Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
4.19 M | 3.94 M | 3.75 M | 2.71 M | 2.39 M | 2.26 M | 2.25 M | 2.14 M | 1.85 M | 1.81 M | 1.79 M | 44.8 M | 30.6 M | 23.8 M | 18 M | 14 M | 9.53 M | 4.51 M | 3.61 M | 3.02 M | 2.37 M | 18.1 M | 1.65 M | 18 M | 17.9 M | 17.6 M | 17.4 M | 17.1 M | 16.9 M | 16.6 M | 16.4 M | 16.1 M | 15.8 M | 15.6 M | 15.3 M | 15 M | 10.2 M | 2.06 M | 1.8 M | 1.54 M | 1.37 M | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-1.72 M | - | -2.44 M | -3.88 M | -5.34 M | - | -14.4 M | -4.72 M | -6.11 M | - | -3.74 M | -3.07 M | -1.85 M | - | -1.72 M | -1.78 M | -2.08 M | - | -2.63 M | -904 K | -1.52 M | -2.01 M | -307 K | 111 K | -382 K | -8.03 M | -9.33 M | -8.8 M | -8.27 M | -7.9 M | -10.6 M | -11.4 M | -9.59 M | -7.89 M | -8.15 M | -7.08 M | -6.02 M | -3.74 M | -1.99 M | -2.19 M | -92.7 K | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | 571 K | 1.27 M | - | 1.38 M | 1.24 M | 1.13 M | - | 875 K | 13.4 K | 13.2 K | 12.4 K | 28.2 K | 51.8 K | 59.6 K | 64.4 K | 77.3 K | 72.3 K | 77.9 K | 84.2 K | 97.7 K | 108 K | 103 K | 37.6 K | 14.6 K | 16.2 K | 3.58 K | 9.36 K | 6.93 K | 2.66 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 36.1 K | 47.3 K | 74.9 K | 91.9 K | 180 K | 83.9 K | 133 K | 149 K | 145 K | 79.1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-1.77 M | - | -2.53 M | -3.97 M | -5.42 M | - | -14.5 M | -4.76 M | -6.12 M | - | -3.75 M | -3.12 M | -1.8 M | - | -1.76 M | -1.9 M | -2.37 M | - | -3.76 M | -912 K | -1.53 M | -2.02 M | -314 K | -9.1 M | -8.28 M | -8.09 M | -9.41 M | -8.88 M | -8.35 M | -7.98 M | -10.7 M | -11.5 M | -9.7 M | - | -8.17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-1.77 M | - | - | - | -5.42 M | - | -14.5 M | -4.76 M | -6.11 M | - | -3.73 M | -3.12 M | -1.8 M | - | -1.75 M | -1.89 M | -2.37 M | - | -3.64 M | -793 K | -1.42 M | -2.02 M | -301 K | -8.98 M | -8.22 M | -8.09 M | -9.16 M | -8.71 M | -8.25 M | -7.98 M | -10.6 M | -11.4 M | -9.66 M | - | -8.13 M | 20.7 K | 9.36 K | - | - | 1.98 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
1.77 M | - | 2.53 M | 3.97 M | 5.42 M | - | 14.5 M | 4.76 M | 6.12 M | - | 3.75 M | 3.69 M | 3.07 M | - | 3.14 M | 3.14 M | 3.5 M | - | 4.64 M | 1.81 M | 2.19 M | 2.18 M | 783 K | 9.35 M | 8.46 M | 8.38 M | 9.82 M | 9.21 M | 8.59 M | 8.28 M | 11.3 M | 11.6 M | 9.7 M | 7.93 M | 8.17 M | 7.09 M | 6.02 M | 3.75 M | 1.99 M | 2.19 M | 92.7 K | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.53 M | - | 1.5 M | 1.62 M | 1.7 M | - | 1.83 M | 1.84 M | 1.68 M | - | 1.73 M | 1.59 M | 1.33 M | - | 1.33 M | 1.7 M | 1.86 M | - | 3.49 M | 968 K | 1.49 M | 1.92 M | 429 K | 2.99 M | 3.7 M | 3.98 M | 4.93 M | 4.99 M | 4.59 M | 3.92 M | 5.45 M | 5.38 M | 5.11 M | 4.62 M | 4.72 M | 3.9 M | 3.22 M | 1.79 M | 1.08 M | 1.09 M | 62.7 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency